Thapsigargin is a plant-derived compound that kills cells by doing two things at once: it drains calcium from the endoplasmic reticulum (the cell’s internal calcium warehouse) and, in doing so, triggers a severe stress response that the cell often cannot survive. It accomplishes this by permanently disabling a single molecular pump, and the downstream consequences ripple through almost every compartment of the cell. That combination has made thapsigargin one of the most widely used tools in cell biology and, more recently, a starting point for experimental cancer drugs and antiviral compounds.
How Thapsigargin Locks the Calcium Pump
Cells maintain a calcium concentration inside the endoplasmic reticulum (ER) that is thousands of times higher than in the surrounding cytoplasm. The protein responsible for pumping calcium back into the ER against that gradient is called SERCA. Thapsigargin binds tightly to the calcium-free form of SERCA, wedging itself into a pocket formed by loops within the pump’s transmembrane segments.1PubMed. Locating the thapsigargin-binding site on Ca(2+)-ATPase by cryoelectron microscopy Once locked in place, the pump cannot shift into the shape it needs to grab and transport calcium, so it simply stops working.2PubMed. Molecular determinants of thapsigargin binding by SERCA Ca2+-ATPase: a computational docking study
The binding is essentially irreversible under normal conditions. Structural studies show that water molecules inside the binding pocket create an extensive network of hydrogen bonds between thapsigargin and the backbone of SERCA, anchoring the drug tightly in a specific orientation.3PubMed. Water-mediated interactions influence the binding of thapsigargin to sarco/endoplasmic reticulum calcium adenosinetriphosphatase This matters because the inhibition is not a brief disruption that the cell can wait out. Once thapsigargin binds, that copy of SERCA is permanently disabled.
What Happens When ER Calcium Drains Away
With SERCA blocked, calcium still leaks out of the ER through channels that are always slightly open. Normally, the pump would push it right back in, but now there is no return trip. The ER progressively loses its calcium stores, and the cytoplasm fills with calcium it was never supposed to hold at those concentrations. This slow leak is measurable: experiments on cells pretreated with thapsigargin show a gradual rise in cytoplasmic calcium even before any other stimulus is applied.4PubMed Central. Molecularly Distinct Routes of Mitochondrial Ca2+ Uptake Are Activated Depending on the Activity of the Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA)
The depleted ER then sends a distress signal to the cell’s outer membrane. A sensor protein in the ER detects the low calcium and migrates to points where the ER nearly touches the plasma membrane. There it activates calcium channels, allowing extracellular calcium to pour in. This process, called store-operated calcium entry (SOCE), was once thought to operate through a single pathway, but research on endothelial cells showed that thapsigargin activates at least two distinct routes of calcium entry. Silencing the genes for the main SOCE machinery only reduced calcium influx by about half to sixty percent, meaning a substantial fraction enters through a separate channel.5Cell Calcium. Thapsigargin activates Ca2+ entry both by store-dependent, STIM1/Orai1-mediated, and store-independent, TRPC3/PLC/PKC-mediated pathways in human endothelial cells In other cell types, knocking down the same sensor and channel proteins essentially abolished SOCE entirely, indicating that the relative importance of each entry pathway varies by cell type.6PubMed Central. Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation
The result is a two-stage calcium flood. First, calcium leaks from the ER into the cytoplasm. Then, SOCE channels open, pulling in even more calcium from outside the cell. The combined effect raises cytoplasmic calcium far beyond normal levels and sets off a chain of damaging events.
The Unfolded Protein Response
Calcium inside the ER is not just a signaling molecule sitting in storage. It is essential for the work of chaperone proteins that fold newly made proteins into their correct three-dimensional shapes. When thapsigargin depletes ER calcium, those chaperones lose their ability to function properly, and misfolded proteins begin to accumulate. The cell detects this buildup and activates a coordinated alarm system.
This alarm, known as the unfolded protein response (UPR), proceeds through several branches. In cardiomyocytes treated with thapsigargin, key stress-sensing proteins were dramatically upregulated: the chaperone GRP78 rose roughly fivefold, and the stress transcription factor ATF4 increased nearly ninefold compared with untreated cells.7PubMed Central. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis induced by thapsigargin through inhibition of endoplasmic reticulum stress In adrenocortical carcinoma cells, thapsigargin boosted expression of multiple UPR pathway components simultaneously, including the PERK and ATF6 branches.8Drug Design, Development and Therapy. Thapsigargin induces apoptosis in adrenocortical carcinoma by activating endoplasmic reticulum stress and the JNK signaling pathway: an in vitro and in vivo study
The initial purpose of the UPR is protective: slow down protein production, ramp up chaperone output, and clear out the misfolded backlog. But thapsigargin’s inhibition of SERCA is permanent, so the stress never resolves. When the UPR runs too long without relief, it flips from a rescue program to a death sentence.
From Stress to Cell Death
Prolonged ER stress pushes the UPR toward activating a protein called CHOP, which is one of the cell’s primary executioners in this context. CHOP turns on genes that open calcium channels in the ER membrane, releasing yet more calcium. That calcium is taken up by mitochondria, which become overloaded and release factors that trigger the cell’s self-destruction machinery.9Acta Biochimica et Biophysica Sinica. New insights into the roles of CHOP-induced apoptosis in ER stress The end result is apoptosis: a controlled demolition of the cell from within.
Thapsigargin-driven cell death involves multiple parallel tracks. Sustained SERCA inhibition depletes ER calcium, which opens plasma membrane channels and rapidly elevates cytoplasmic calcium. This elevation activates enzymes that directly cut cellular DNA and triggers the release of apoptotic factors from mitochondria.10PubMed Central. Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours The cell is hit from multiple directions simultaneously, which makes thapsigargin exceptionally potent as a cell killer and also exceptionally difficult for cells to defend against.
Calcium Transfer Between the ER and Mitochondria
The ER and mitochondria are not isolated compartments. They physically touch at specialized contact sites, and calcium passes between them through these junctions. Under normal conditions, when the ER releases a burst of calcium in response to a signal, nearby mitochondria rapidly scoop it up. This transfer is fast and efficient because the two organelles are positioned close enough that calcium concentration at the contact point is very high.
Thapsigargin disrupts this arrangement in a counterintuitive way. You might expect that flooding the cytoplasm with calcium would also flood the mitochondria, but the reality is more subtle. When cells were pretreated with thapsigargin, the slow leak from the ER raised cytoplasmic calcium only modestly, and that gradual signal was not enough to trigger significant mitochondrial uptake. When a second stimulus was then added to release any remaining ER calcium, both the cytoplasmic and mitochondrial calcium signals were slower and the time gap between them widened considerably.4PubMed Central. Molecularly Distinct Routes of Mitochondrial Ca2+ Uptake Are Activated Depending on the Activity of the Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA) In other words, SERCA inhibition decelerates the normal rapid transfer of calcium into mitochondria by preventing the ER from producing the sharp, concentrated bursts of calcium that mitochondria are designed to capture.
The protein BOK, which sits at ER-mitochondria contact sites, appears to regulate this transfer. Cells lacking BOK showed significantly decreased mitochondrial calcium uptake in response to thapsigargin, suggesting that the structural integrity of these contact sites matters for how much calcium the mitochondria ultimately absorb.11Cell Reports. BOK regulates the calcium transfer at mitochondria-associated endoplasmic reticulum membranes
Autophagy, Inflammation, and Other Downstream Effects
Cell death is not the only outcome of thapsigargin treatment. At lower concentrations or shorter exposures, cells mount survival responses. One of these is autophagy, the cell’s recycling program, where damaged components are enclosed in membranes and delivered to lysosomes for digestion. Thapsigargin activates autophagy through an energy-sensing pathway that also involves a low-oxygen response factor called HIF-1.12PubMed Central. Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression This likely represents the cell’s attempt to clean up the mess of misfolded proteins and damaged organelles before the situation becomes irreversible.
Thapsigargin-induced ER stress also activates the inflammatory machinery. ER stress can turn on a multi-protein complex called the NLRP3 inflammasome, which triggers the release of the pro-inflammatory signal interleukin-1β. This activation requires reactive oxygen species and potassium efflux, similar to other inflammasome triggers, but proceeds independently of the classical UPR.13PubMed Central. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway The distinction matters because it means ER stress can provoke inflammation through a route that bypasses the cell’s normal protein-folding stress sensors. In tissues where chronic ER stress is already present, this could contribute to sustained inflammation without the usual UPR markers being elevated.
SOCE and the Cell Cycle
Store-operated calcium entry does not just affect cell survival; it influences when and whether cells divide. Using thapsigargin to trigger SOCE in cancer cell lines, researchers found that the magnitude of calcium influx changed depending on where the cell was in its division cycle. SOCE was upregulated during the transition from the growth phase to the DNA-copying phase and downregulated as the cell moved toward actual division.14Scientific Reports. The STIM1-Orai1 pathway of store-operated Ca2+ entry controls the checkpoint in cell cycle G1/S transition This means that the calcium entry pathway thapsigargin activates is already serving as a checkpoint that controls cell proliferation. Disrupting it does not just stress the cell; it also jams the signals that govern division timing.
Cancer Research and Prodrug Design
Thapsigargin’s ability to kill cells indiscriminately might seem like a drawback for medicine, but researchers have turned it into a feature. Because thapsigargin kills both normal and malignant cells, the strategy is not to deliver it systemically but to activate it only at the tumor site. A prodrug called mipsagargin attaches thapsigargin to a peptide that is cleaved by an enzyme found on tumor blood vessels and on certain cancer cells. In theory, the drug remains inactive in the bloodstream and becomes toxic only after reaching the tumor’s neighborhood.10PubMed Central. Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours This approach completed a first-in-human clinical trial in patients with advanced solid tumors, though the compound remains experimental.
A complicating factor for any thapsigargin-based cancer therapy is that cancer cells can develop resistance. Prostate cancer cell lines exposed to increasing concentrations of thapsigargin over time developed resistance ranging from 60-fold to over 1,300-fold.15PubMed. Mechanisms of resistance and adaptation to thapsigargin in androgen-independent prostate cancer PC3 and DU145 cells In some resistant lines, the cells simply produced more SERCA protein, overwhelming the drug by sheer numbers of pumps. But knocking down SERCA in the most resistant cells only partially reversed their resistance, meaning additional, still-unidentified mechanisms were also at work.16PubMed. Thapsigargin resistance in human prostate cancer cells Interestingly, different prostate cancer cell lines recruited entirely different sets of genes to achieve the same resistant outcome, and none of the resistant cells showed cross-resistance to other drugs. The resistance was specific to thapsigargin.
Neuronal Cells That Adapt to Chronic ER Stress
Resistance is not limited to cancer. Neuronal cell lines chronically exposed to thapsigargin can also survive what would normally be lethal ER stress. These adapted cells underwent dramatic internal remodeling: they developed large numbers of vesicles and autophagosomes (the recycling structures mentioned earlier), including unusually enlarged lysosomes. Their metabolism shifted toward aerobic glycolysis, a less efficient but faster way of generating energy, and their mitochondrial machinery showed defects in one of the main complexes of energy production.17PubMed Central. Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress These cells essentially rebuilt their internal economy to survive without a functioning ER calcium store, at the cost of becoming metabolically abnormal.
In neurons that are not adapted, thapsigargin is straightforwardly damaging. Cortical neurons treated with the compound showed dramatic oxidative stress and apoptosis driven by uncontrolled calcium entry.18PubMed Central. Pink1 protects cortical neurons from thapsigargin-induced oxidative stress and neuronal apoptosis This makes thapsigargin a common laboratory tool for modeling aspects of neurodegenerative diseases, where ER stress and calcium dysregulation are thought to contribute to the progressive loss of neurons.
How Thapsigargin Compares With Other ER Stress Inducers
Thapsigargin is not the only compound used to stress the ER in laboratory settings. Tunicamycin, which blocks a different process (the attachment of sugar chains to newly made proteins), is its most common alternative. The two drugs disrupt ER function through fundamentally different mechanisms: thapsigargin drains calcium while tunicamycin gums up protein processing directly.19Cell Death Discovery. ER stress-induced cell death proceeds independently of the TRAIL-R2 signaling axis in pancreatic β cells
In practice, the two do not always produce equivalent results. In fat cells, tunicamycin was more consistently effective at inducing ER stress, while in liver cells the two were roughly equal. In whole-animal experiments, tunicamycin was superior at both inducing ER stress and reproducing the metabolic disruptions associated with it.20PubMed Central. Modeling Acute ER Stress in Vivo and in Vitro The chronic-adaptation studies in neuronal cells also revealed different remodeling profiles depending on which drug was used: cells resistant to thapsigargin activated different gene clusters and stress pathways than cells resistant to tunicamycin, even though both had survived prolonged ER stress.17PubMed Central. Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress Researchers choosing between the two need to consider which aspect of ER stress they want to model, because the downstream consequences are not interchangeable.
Effects on Heart Muscle Cells
Heart cells depend heavily on precisely timed calcium cycling to contract and relax. The calcium pump that thapsigargin targets is the same one that reloads the internal calcium store between each heartbeat, so blocking it has immediate consequences. In isolated rat heart cells, a concentration of 300 nanomolar thapsigargin completely abolished contractile activity. At lower doses, contractions became sluggish: the time needed to reach peak contraction roughly doubled, and the relaxation phase stretched out considerably.21PubMed. Effect of thapsigargin on cardiac muscle cells
Guinea pig heart cells showed a similar pattern. Thapsigargin slowed the rapid rise of intracellular calcium that normally initiates contraction and increased the time to reach peak calcium from roughly 160 milliseconds to nearly 400 milliseconds. Once the drug’s effects were fully established, the cells no longer responded to caffeine, a standard test that works by releasing calcium from the internal store. The calcium current flowing in through the cell membrane itself was unaffected, confirming that thapsigargin specifically impairs the internal store rather than the membrane channels.22PubMed. Effects of thapsigargin in normal and pretreated with ryanodine guinea pig cardiomyocytes In these treated cells, contractions were driven entirely by calcium entering from outside, without any contribution from the internal reserve. That arrangement can sustain a heartbeat of sorts, but not one with the speed and force a working heart requires.
Antiviral Properties
One of the more unexpected chapters in thapsigargin research is the discovery that it has pronounced antiviral activity against several enveloped RNA viruses, including SARS-CoV-2, MERS-CoV, and influenza A. The antiviral effect appears to work through the host cell rather than targeting the virus directly, which means it could be harder for viruses to develop resistance against it.23PubMed Central. Thapsigargin: key to new host-directed coronavirus antivirals? The logic is that by disrupting ER calcium and triggering the UPR, thapsigargin cripples the cellular machinery that viruses hijack to replicate. Enveloped viruses are especially dependent on the ER’s protein-processing and membrane-building equipment, so stressing that system could impair viral production at multiple stages simultaneously. This remains early-stage research, and thapsigargin’s toxicity to normal cells is the obvious obstacle to any direct clinical use. But the finding has spurred interest in whether less-toxic derivatives or low-dose regimens could capture the antiviral benefit while limiting cellular damage.
Where Thapsigargin Comes From
Thapsigargin is a natural product, extracted from the roots of Thapsia garganica, a plant native to the Mediterranean region and North Africa. The plant has long been recognized as toxic to grazing animals.24PubMed. Thapsia garganica L: a poisonous plant of North Africa Farmers in the region traditionally knew to keep livestock away from it, though the molecular basis of its toxicity was not understood until thapsigargin was isolated and its mechanism of SERCA inhibition characterized. The compound’s ability to form stable complexes with SERCA has also been a gift to structural biologists: thapsigargin-bound SERCA locks the pump in a single conformation, which made it possible to crystallize and solve the three-dimensional structure of the calcium-free state of the enzyme.25PubMed. From Plant to Patient: Thapsigargin, a Tool for Understanding Natural Product Chemistry, Total Syntheses, Biosynthesis, Taxonomy, ATPases, Cell Death, and Drug Development In that sense, the same property that makes thapsigargin dangerous to cells also made it indispensable for understanding the very pump it destroys.